Physician profile
Anna Jung
NPI 1063687333
$943.51
in general payments reported to CMS, 2019-2025
19 companies · $75.56 in 2025
The $75.56 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.46 · 2020: $85.72 · 2021: $158 · 2022: $262 · 2023: $267 · 2024: $20.77 · 2025: $75.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $182.35 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $92.47 | 2022-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Pfizer INC. | $88.36 | 2020-2023 | |
| Nestle Healthcare Nutrition INC. | $87.49 | 2021-2023 | |
| Cranial Technologies, INC | $82.20 | 2021-2023 | Doc Band |
| Sanofi-Aventis U.S. LLC | $55.65 | 2023-2025 | |
| Lilly USA, LLC | $52.22 | 2022-2025 | Omvoh |
| Adlon Therapeutics L.P. | $42.86 | 2020-2021 | |
| Acclarent, INC | $37.45 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.85 | 2020-2021 | |
| Glaxosmithkline, LLC. | $33.66 | 2020-2023 | Trelegy Ellipta |
| Supernus Pharmaceuticals, INC. | $30.63 | 2023 | Qelbree |
| Sanofi Pasteur INC. | $29.83 | 2022 | |
| Corium, LLC | $19.34 | 2021 | |
| Lifescan, INC. | $17.67 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $16.76 | 2020 | |
| Sarepta Therapeutics, INC. | $14.19 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.36 | 2022 | |
| Sobi, INC | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.